Sep 24, 2026
Could a new generation of therapies eventually reproduce some of the effects we associate with diet and exercise? In this episode, we connect with Dr. Adam Dorr to discuss the rapid evolution of GLP-1 medications and the possibility that combining fat-loss drugs with emerging myostatin- and activin-blocking therapies...
Aug 17, 2026
Could the brain’s metabolism play a bigger role in mental health than we realize? In this episode, Dr. Matt Bernstein, Chief Medical Officer at Ellenhorn and CEO of Accord, explores the emerging field of metabolic psychiatry and its potential to reshape how we understand and approach complex psychiatric conditions.